- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, May 29, 2020
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece by RevCycleIntelligence referenced a study published in the May 2020 issue of The American Journal of Managed Care® (AJMC®), titled “Accountable Care Organizations Are Increasingly Led by Physician Groups Rather Than Hospital Systems.” The study indicated that the growing shift toward physician-led accountable care organizations (ACOs) rather than hospital systems since 2015 requires policies that address the characteristic strengths and weaknesses of physician-led ACOs.
An article posted on amny.com cited a study published in a supplement of AJMC®, “The Essential Role of Community Pharmacies in Expanding Access to Vaccines.” The study highlighted how pharmacists are ideally positioned to overcome barriers to improving adult vaccination rates, which extend from a lack of public awareness regarding the need for vaccines and the ongoing threat of vaccine-preventable diseases to challenges regarding financial/reimbursement systems for providers.
Sequencing CAR T and Bispecifics for Multiple Myeloma: Tyler Sandahl, PharmD
July 8th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, while bispecific antibodies are reserved for later lines or for patients unable to tolerate CAR T.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
Driving Value via Outcomes-Based Pricing and EHR Interoperability: Tyler Sandahl, PharmD
July 7th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, discussed the complexities of alternative payment models for chimeric antigen receptor T-cell and bispecific therapies and the need for improved data sharing in cancer care.
Read More
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD
June 19th 2025Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
Read More
